EORTC QLQ-C30 normative data for the United Kingdom : Results of a cross-sectional survey of the general population
Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved..
OBJECTIVE: The cancer-specific health-related quality of life (HRQoL) questionnaire of the European Organisation for Research and Treatment of Cancer (EORTC), the EORTC QLQ-C30, is a frequently applied questionnaire to assess cancer patients' self-reported health used as part of research and clinical practice. Normative data obtained from the general population can facilitate the interpretation of these data. Despite its frequent application, no detailed EORTC QLQ-C30 normative data have yet been published for the United Kingdom (UK). This study presents detailed EORTC QLQ-C30 normative data for the United Kingdom overall and by sex and age.
METHODS: The data are drawn from a larger published, international, cross-sectional online survey. For the recruitment, the sample was stratified by sex (males, females) and age in five age groups with a sample size of n = 100 per subgroup.
RESULTS: A total of N = 1026 UK respondents completed the survey (n = 517 females, n = 509 males). There were no clear subgroup patterns by sex or age; however, older patients tended to show higher (i.e., better) scores in emotional and social functioning; they also reported some of the lowest (i.e., best) scores for symptoms, such as insomnia, appetite loss, diarrhoea, nausea/vomiting or financial difficulties.
CONCLUSION: This paper provides EORTC QLQ-C30 general population normative data for the UK, further stratified by sex and age. These data will greatly support the interpretation of EORTC QLQ-C30 scale scores obtained from UK cancer patients, and also enable comparison with other detailed national normative datasets collected in the same project, across several other European countries and the US.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
---|---|
Enthalten in: |
European journal of cancer (Oxford, England : 1990) - (2024) vom: 17. Feb., Seite 113927 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Young, Teresa [VerfasserIn] |
---|
Links: |
---|
Themen: |
Cancer |
---|
Anmerkungen: |
Date Revised 01.03.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.1016/j.ejca.2024.113927 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369190459 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM369190459 | ||
003 | DE-627 | ||
005 | 20240302232925.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240302s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ejca.2024.113927 |2 doi | |
028 | 5 | 2 | |a pubmed24n1314.xml |
035 | |a (DE-627)NLM369190459 | ||
035 | |a (NLM)38429166 | ||
035 | |a (PII)S0959-8049(24)00103-5 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Young, Teresa |e verfasserin |4 aut | |
245 | 1 | 0 | |a EORTC QLQ-C30 normative data for the United Kingdom |b Results of a cross-sectional survey of the general population |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 01.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved. | ||
520 | |a OBJECTIVE: The cancer-specific health-related quality of life (HRQoL) questionnaire of the European Organisation for Research and Treatment of Cancer (EORTC), the EORTC QLQ-C30, is a frequently applied questionnaire to assess cancer patients' self-reported health used as part of research and clinical practice. Normative data obtained from the general population can facilitate the interpretation of these data. Despite its frequent application, no detailed EORTC QLQ-C30 normative data have yet been published for the United Kingdom (UK). This study presents detailed EORTC QLQ-C30 normative data for the United Kingdom overall and by sex and age | ||
520 | |a METHODS: The data are drawn from a larger published, international, cross-sectional online survey. For the recruitment, the sample was stratified by sex (males, females) and age in five age groups with a sample size of n = 100 per subgroup | ||
520 | |a RESULTS: A total of N = 1026 UK respondents completed the survey (n = 517 females, n = 509 males). There were no clear subgroup patterns by sex or age; however, older patients tended to show higher (i.e., better) scores in emotional and social functioning; they also reported some of the lowest (i.e., best) scores for symptoms, such as insomnia, appetite loss, diarrhoea, nausea/vomiting or financial difficulties | ||
520 | |a CONCLUSION: This paper provides EORTC QLQ-C30 general population normative data for the UK, further stratified by sex and age. These data will greatly support the interpretation of EORTC QLQ-C30 scale scores obtained from UK cancer patients, and also enable comparison with other detailed national normative datasets collected in the same project, across several other European countries and the US | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Cancer | |
650 | 4 | |a Normative data | |
650 | 4 | |a Patient reported outcome measures | |
650 | 4 | |a Quality of life | |
650 | 4 | |a Reference values | |
650 | 4 | |a United Kingdom | |
700 | 1 | |a Velikova, Galina |e verfasserin |4 aut | |
700 | 1 | |a Liegl, Gregor |e verfasserin |4 aut | |
700 | 1 | |a Rose, Matthias |e verfasserin |4 aut | |
700 | 1 | |a Nolte, Sandra |e verfasserin |4 aut | |
700 | 0 | |a EORTC Quality of Life Group |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t European journal of cancer (Oxford, England : 1990) |d 1991 |g (2024) vom: 17. Feb., Seite 113927 |w (DE-627)NLM012602779 |x 1879-0852 |7 nnns |
773 | 1 | 8 | |g year:2024 |g day:17 |g month:02 |g pages:113927 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ejca.2024.113927 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2024 |b 17 |c 02 |h 113927 |